Valuation: PharmaEssentia Corporation

Market Cap 481B 14.77B 13.15B 12.17B 11.03B 20.7B 1,402B 21.01B 146B 57.84B 734B 55.43B 54.24B 2,318B P/E 2026 *
44x
P/E 2027 * 27.2x
Enterprise Value 458B 14.06B 12.52B 11.59B 10.5B 19.71B 1,335B 20B 139B 55.06B 699B 52.77B 51.64B 2,207B EV / Sales 2026 *
16.9x
EV / Sales 2027 * 10.8x
Free-Float
79.23%
Yield 2026 *
0.34%
Yield 2027 * 0.2%
1 day-1.28%
1 week-6.83%
Current month-4.53%
1 month+0.43%
3 months+2.20%
6 months+107.54%
Current year+173.78%
1 week 1,155
Extreme 1155
1,250
1 month 1,140
Extreme 1140
1,300
Current year 423.7
Extreme 423.699083
1,645
1 year 407.92
Extreme 407.923053
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 73.19
Extreme 73.192531
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 2016-12-31
Director of Finance/CFO - 2015-10-13
President - 2015-06-24
Director TitleAgeSince
Director/Board Member - 2000-05-08
Chairman - 2012-09-23
Director/Board Member - 2015-05-28
Change 5-day change 1-year change 3-year change Capi.($)
-1.28%-6.83%+155.82%+340.73% 14.75B
+2.41%+0.29%+39.41%+72.14% 64.69B
-0.15%+7.50%+11.42%+71.27% 54.78B
+0.57%+4.60%+7.71%+90.93% 53.49B
+0.37%+4.67%+26.68%+49.64% 45.98B
-1.21%+2.32%+21.50%+118.33% 42.94B
-0.37%+5.07%+243.23%+789.58% 40.08B
+0.05%+0.21%+18.06%+48.50% 33.52B
+1.19%-4.98%+26.31%-0.76% 23.97B
-0.38%+5.68%+38.39%+28.35% 23.67B
Average +0.12%+1.49%+58.85%+160.87% 39.79B
Weighted average by Cap. +0.33%+2.38%+50.09%+150.17%

Financials

2026 *2027 *
Net sales 27.07B 832M 740M 685M 621M 1.17B 78.95B 1.18B 8.24B 3.26B 41.35B 3.12B 3.05B 131B 41.5B 1.27B 1.14B 1.05B 952M 1.79B 121B 1.81B 12.63B 4.99B 63.4B 4.79B 4.68B 200B
Net income 10.52B 323M 288M 266M 241M 453M 30.69B 460M 3.2B 1.27B 16.08B 1.21B 1.19B 50.75B 17.96B 552M 491M 455M 412M 774M 52.38B 785M 5.46B 2.16B 27.44B 2.07B 2.03B 86.63B
Net Debt -23.05B -708M -630M -584M -529M -993M -67.21B -1.01B -7.01B -2.77B -35.21B -2.66B -2.6B -111B -34.24B -1.05B -937M -867M -786M -1.47B -99.86B -1.5B -10.42B -4.12B -52.31B -3.95B -3.86B -165B
Projected Income Statement - Annual - PharmaEssentia Corporation
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
26-10-22 NT$1,160.00 -1.28% 1,195,618
26-10-21 NT$1,175.00 +1.73% 1,496,190
26-10-20 NT$1,155.00 -1.70% 1,374,418
26-10-19 NT$1,175.00 -5.62% 2,610,708
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - PharmaEssentia Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,160.00TWD
Average target price
1,437.27TWD
Spread / Average Target
+23.90%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PharmaEssentia Corporation
  1. Stock Market
  2. Stocks
  3. 6446 Stock